Macaluso LLP Corporate & Financial Law
Macaluso LLP Corporate & Financial Law

A Rare Depth Of Experience At The Highest Levels Of Business And Finance

  1. Macaluso LLP
    2.  → 
  2. Experience
    3.  → Commercialization

Selected Experience Involving Commercialization

Macaluso LLP represented the U.S. office of a global sovereign wealth fund as lead investor in a $180 million structured investment backed by crop loans.

ABS, AGRICULTURE, ASIA, FINANCIAL SERVICES, FUNDS, GOVERNMENT, INTERNATIONAL, SECURITIES OFFERINGS, STRUCTURED FINANCE, COMMERCIALIZATION, CAPITAL MARKETS

Macaluso LLP assisted a U.S.-based family office in the sale of its nanotech portfolio business located in international affiliates in Japan, Singapore, and Israel to a NASDAQ listed company.

M&A, TECHNOLOGY, INTERNATIONAL, COMMERCIALIZATION, SECURITIES OFFERINGS, ASIA, MIDDLE EAST, REGULATORY, CAPITAL MARKETS

Macaluso LLP assisted a blockchain-enabled secured mortgage aggregation platform operating as a DAO in connection with the legal structure of its base platform and operations.

TECHNOLOGY, STRUCTURED FINANCE, COMMERCIALIZATION, FINANCIAL SERVICES, ABS, SECURITIES OFFERINGS, CAPITAL MARKETS

Macaluso LLP represents a gaming company in connection with the building of its own platform for a blockchain and NFT-based “metaverse” VR game for the Oculus platform.

TECHNOLOGY, COMMERCIALIZATION, SPORTS & ENTERTAINMENT

Counsel to a healthcare company in the growth stage currently rolling out its cardiovascular program in Asia. Working in five countries and ultimately rolling the program out in over 30 countries in the region. Set up U.S. and Hong Kong operations. Responsible for managing the local medical privacy, local FDA and regulatory approach. Working with partners and investors across U.S. and Asia. Also represent the company in its Middle-East expansion beginning in the U.A.E.

HEALTHCARE, INTERNATIONAL, ASIA, MIDDLE EAST, REGULATORY, COMMERCIALIZATION, CAPITAL MARKETS

Assisted leading medical research institution and related entities in connection with their efforts to commercialize intellectual properties.

HEALTHCARE, COMMERCIALIZATION, M&A, INTERNATIONAL, REGULATORY, SECURITIES OFFERINGS, TECHNOLOGY, U.S., SOCIAL IMPACT, CAPITAL MARKETS

Acted as chief strategist in the restructuring of several portfolio companies of a fund in the healthcare, life science, IP, and tech sectors, commercializing medical related advances of prominent medical research institutions.

COUNSEL SERVICES, HEALTHCARE, TECHNOLOGY, FUNDS, COMMERCIALIZATION, M&A, SECURITIES OFFERINGS, CAPITAL MARKETS